Rafael Holdings, Inc.

NYSE:RFL Stock Report

Market Cap: US$69.2m

Rafael Holdings Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Rafael Holdings.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth14.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article Mar 26

Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Oct 11

Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Mar 21

Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)

Rafael Holdings, Inc.'s ( NYSE:RFL ) healthy profit numbers didn't contain any surprises for investors. We think this...
Analysis Article Aug 04

We Think Rafael Holdings (NYSE:RFL) Needs To Drive Business Growth Carefully

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Seeking Alpha Dec 13

Rafael Holdings GAAP EPS of -$0.22

Rafael Holdings press release (NYSE:RFL): FQ1 GAAP EPS of -$0.22 (vs. -$5.88 Y/Y). As of Oct. 31, the company had cash, cash equivalents and marketable securities of $93.8M, which includes $33M in net proceeds from the sale of real estate assets on Aug. 22.
Seeking Alpha Nov 16

Rafael stepping back from early-stage development in favor of acquisition, licensing

Rafael Holdings (NYSE:RFL) is putting the brakes on its early-stage development programs as part of an effort to reduce spending and instead focus on investing in, acquiring, or in-licensing clinical-stage candidates. CEO Bill Conkling said that by doing so, Rafael (RFL) has the "potential to achieve meaningful clinical milestones, which if successful, could improve the lives of patients and increase value for our shareholders." As of July 31, the Company had cash, cash equivalents and marketable securities of $63.2M, and then an additional $33M in net proceeds from the sale of real estate assets on August 23. The stock is down ~63% year to date.
Analysis Article Jan 20

Is Rafael Holdings (NYSE:RFL) Using Debt In A Risky Way?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seeking Alpha Nov 18

Rafael Holdings: A Coin Flip

RFL has a large bet on one drug for cancer treatment. This important bet just recently failed to succeed as a treatment for one type of cancer, with other studies ongoing. Aside from some real estate side income, RH is a generic biotech coin flip.
Seeking Alpha Jun 21

Rafael Holdings announces merger with Rafael Pharmaceuticals

Zhanna Hapanovich/iStock via Getty Images Rafael Holdings (RFL) has added ~7.4% in the premarket after announcing a merger agreement with Rafael Pharmaceuticals, a private-owned late-stage oncology company in which the former and its subsidiaries has a majority stake. The president and CEO of Rafael Pharmaceuticals Sanjeev Luther will join the board of directors of the combined company which will be led by Ameet Mallik as the CEO and Howard Jonas as the chairman. The merged company will retain the name of Rafael
Analysis Article Jan 25

What You Need To Know About Rafael Holdings, Inc.'s (NYSE:RFL) Investor Composition

A look at the shareholders of Rafael Holdings, Inc. ( NYSE:RFL ) can tell us which group is most powerful. Institutions...
Analysis Article Dec 01

The Rafael Holdings (NYSE:RFL) Share Price Has Gained 29% And Shareholders Are Hoping For More

Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rafael Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NYSE:RFL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
1/31/20261-33-28-28N/A
10/31/20251-31-23-23N/A
7/31/20251-31-19-19N/A
4/30/20251-23-11-11N/A
1/31/20251-50-8-8N/A
10/31/20241-40-8-9N/A
7/31/20241-34-8-8N/A
4/30/20241-29-6-6N/A
1/31/202402-7-7N/A
10/31/20230-7-10-10N/A
7/31/20230-8-11-11N/A
4/30/20230-14-11-11N/A
1/31/20230-18-20-20N/A
10/31/20220-16-22-22N/A
7/31/20220-123-26-26N/A
4/30/2022-2-129-31-31N/A
1/31/2022-1-127-24-24N/A
10/31/20210-133-19-19N/A
7/31/20211-23-16-16N/A
4/30/20214-18-10-10N/A
1/31/20214-17-8-8N/A
10/31/20205-10-6-6N/A
7/31/20205-10-5-5N/A
4/30/20205-7-4-4N/A
1/31/20205-6-4-4N/A
10/31/20195-6N/A-3N/A
7/31/20195-5N/A-3N/A
4/30/20195-4N/A-3N/A
1/31/20194-3N/A-3N/A
10/31/20184-3N/A-3N/A
7/31/20184-12N/A-2N/A
4/30/20185-10N/A-2N/A
1/31/20185-10N/A-1N/A
10/31/20175-9N/A-1N/A
7/31/201760N/A-2N/A
7/31/201661N/A0N/A
7/31/201540N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if RFL's forecast earnings growth is above the savings rate (3.5%).

Earnings vs Market: Insufficient data to determine if RFL's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if RFL's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if RFL's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if RFL's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if RFL's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/22 02:00
End of Day Share Price 2026/05/22 00:00
Earnings2026/01/31
Annual Earnings2025/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rafael Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.